QUIDELORTHO CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 39.64 USD | -0.13% |
|
+1.33% | -46.21% |
| 04-02 | QuidelOrtho Shares Fall on Decision to Withdraw FDA 510(k) Submission for Savanna RVP4+ Assay | MT |
| 04-02 | QuidelOrtho Gets US FDA Clearance For QuickVue COVID-19 Test | MT |
Chart calendar QuidelOrtho Corporation
c93c25ad72880fa104d1379.NrhoZ0dnGVggCD-FAy_XFuONJxsp9uxMJldGD1G6oV8.AIBFCCQeew5RYE3rd06OZob5Sn1tmY95EWVxaTXz4w1j8gIRLgEvbxdhfg~a9da85008dffcaadaf03b2f2fe8178f6
Upcoming events on QuidelOrtho Corporation
Past events on QuidelOrtho Corporation
| 05/03/2024 21:00 | Raymond James Institutional Investors Conference |
| 13/02/2024 22:00 | Q4 2023 Earnings Call |
| 13/02/2024 21:05 | Q4 2023 Earnings Release |
| 08/01/2024 17:00 | JPMorgan Healthcare Conference |
| 30/11/2023 14:10 | Evercore ISI HealthCONx Conference |
| 01/11/2023 21:00 | Q3 2023 Earnings Call |
| 01/11/2023 20:05 | Q3 2023 Earnings Release |
| 12/09/2023 19:55 | Morgan Stanley Global Healthcare Conference |
| 08/08/2023 22:00 | Q2 2023 Earnings Call |
| 08/08/2023 21:30 | Q2 2023 Earnings Release |
| 06/06/2023 20:00 | William Blair Growth Stock Conference |
| 16/05/2023 16:30 | Annual General Meeting |
| 03/05/2023 22:00 | Q1 2023 Earnings Call |
| 03/05/2023 21:05 | Q1 2023 Earnings Release |
| 07/03/2023 16:35 | Raymond James Institutional Investors Conference |
| 15/02/2023 22:00 | FY 2022 Earnings Call |
| 15/02/2023 21:05 | FY 2022 Earnings Release |
| 09/01/2023 17:00 | JP Morgan Healthcare Conference |
| 13/12/2022 18:00 | Investor Day |
| 02/11/2022 21:00 | Q3 2022 Earnings Call |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 535 531 0.76% | 1 662 1 663 -0.08% | 1 699 1 579 7.56% | 3 266 3 548 -7.96% | 2 998 3 043 -1.48% | 2 794 |
|
EBITDA Million USD | Released Forecast Spread | 156 162 -3.33% | 1 109 1 084 2.31% | 996 913 9.11% | 1 331 1 381 -3.63% | 723 804 -10.03% | 595 |
|
EBIT Million USD | Released Forecast Spread | 92,7 92,4 0.34% | 1 060 1 004 5.56% | 906 823 10.04% | 844 1 072 -21.28% | 139 591 -76.47% | 304 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 77,2 78,4 -1.5% | 1 040 968 7.47% | 900 818 10.04% | 736 766 -3.93% | -29,1 91,9 -131.68% | -117 |
|
Net income Million USD | Released Forecast Spread | 72,9 69,4 5.07% | 810 769 5.38% | 704 644 9.34% | 549 543 1.06% | -10,1 71,3 -114.17% | -65,0 |
|
EPS USD | Released Forecast Spread | 1,73 1,59 8.58% | 18,6 17,7 4.91% | 16,4 15,0 9.31% | 9,56 9,34 2.33% | -0,15 1,07 -114.07% | -1,13 |
| Announcement Date | 12/02/20 | 18/02/21 | 17/02/22 | 15/02/23 | 13/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 637 517 23.1% | 1 002 865 15.86% | 613 708 -13.41% | 784 720 8.92% | 867 776 11.69% | 846 772 9.58% | 665 615 8.22% | 744 692 7.47% | 743 787 -5.7% | 698 | 644 | 680 | 771 | 705 |
|
EBITDA Million USD | Released Forecast Spread | 406 320 26.81% | 648 498 30.15% | 218 255 -14.58% | 227 162 39.98% | 245 220 11.27% | 245 218 12.45% | 113 114 -0.41% | 169 147 15.21% | 195 276 -29.2% | 149 | 98,1 | 136 | 209 | 176 |
|
EBIT Million USD | Released Forecast Spread | 377 294 28.1% | 621 518 19.75% | 79,7 137 -41.74% | 56,8 48,7 16.52% | 86,5 139 -37.97% | 131 163 -19.49% | 60,1 63,9 -5.98% | 26,3 92,7 -71.64% | 40,1 219 -81.72% | 76,3 | 24,8 | 65,1 | 138 | 89,6 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 375 293 27.99% | 621 518 19.93% | 42,9 119 -64.04% | 31,3 16,4 90.53% | 41,1 71,0 -42.11% | 60,0 75,6 -20.58% | -64,4 -44,1 -46.01% | -15,5 -29,8 47.99% | -9,20 112 -108.23% | -35,3 | -97,0 | -42,9 | 38,5 | 8,88 |
|
Net income Million USD | Released Forecast Spread | 291 231 26.02% | 480 409 17.44% | 19,3 94,4 -79.56% | 19,2 11,8 62.03% | 30,3 55,0 -44.93% | 48,8 57,3 -14.82% | -53,2 -24,9 -113.59% | -12,7 -14,3 10.94% | 7,00 91,4 -92.34% | -27,1 | -73,5 | -32,2 | 29,3 | 6,41 |
|
EPS USD | Released Forecast Spread | 6,85 5,39 27.01% | 11,3 8,94 26.51% | 0,36 1,91 -81.14% | 0,28 0,31 -10.2% | 0,45 0,74 -38.95% | 0,73 0,80 -9.17% | -0,80 -0,38 -110.1% | -0,19 -0,25 22.87% | 0,10 1,32 -92.42% | -0,45 | -1,02 | -0,47 | 0,43 | 0,10 |
| Announcement Date | 17/02/22 | 04/05/22 | 04/08/22 | 02/11/22 | 15/02/23 | 03/05/23 | 08/08/23 | 01/11/23 | 13/02/24 | - | - | - | - | - |
More events
Past sector events for QuidelOrtho Corporation
| 25/04/2024 07:00 | BIOTAGE AB: Q1 2024 Earnings Release |
| 24/04/2024 | CONTEC MEDICAL SYSTEMS CO.,LTD: Q4 2023 Earnings Release |
| 24/04/2024 | REVENIO GROUP OYJ: Q1 2024 Earnings Release |
| 21/04/2024 | SHANGHAI MICROPORT EP MEDTECH CO., LTD.: Q1 2024 Earnings Release (Projected) |
| 18/04/2024 | SHANGHAI AOHUA PHOTOELECTRICITY ENDOSCOPE CO., LTD.: Q1 2024 Earnings Release (Projected) |
| 18/04/2024 06:00 | SARTORIUS AG: Q1 2024 Earnings Release |
| 09/04/2024 | SHANGHAI AOHUA PHOTOELECTRICITY ENDOSCOPE CO., LTD.: Q4 2023 Earnings Release |
| 29/03/2024 | SHANGHAI MICROPORT EP MEDTECH CO., LTD.: Q4 2023 Earnings Release |
| 15/02/2024 13:00 | BIOTAGE AB: Q4 2023 Earnings Release |
| 15/02/2024 07:00 | REVENIO GROUP OYJ: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- QDEL Stock
- Calendar QuidelOrtho Corporation
